Trials / Completed
CompletedNCT05730660
Quercetin Phytosome® Chronic Fatigue Symptoms
Effectiveness of a 3-months Dietary Supplementation Based on Quercetin Phytosome®) for the Treatment of Chronic Fatigue Symptoms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Azienda di Servizi alla Persona di Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether a 3-month period of quercetin supplementation (500 mg of Quercetin Phytosome®) is useful in the treatment of chronic fatigue, as assessed by the Fatigue Impact Scale (FIS-40). Secondary end points are sleep assessment through Pittsburgh Sleep Quality Index (PSQI) and muscle performance assessment through the Short Physical Performance Battery (SPPB) and body composition assessment using DXA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Quercetin group | 2 capsules a day of Quercetin Fitosoma® of 250 mg each |
| DIETARY_SUPPLEMENT | Placebo group | 2 tablets per day, white film-coated having the same appearance as Quercetin Fitosoma ® tablets. |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2022-12-31
- Completion
- 2023-01-31
- First posted
- 2023-02-16
- Last updated
- 2024-08-06
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05730660. Inclusion in this directory is not an endorsement.